Literature DB >> 10840163

Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells.

T Tomita1, M Fujii, Y Tokumaru, Y Imanishi, M Kanke, T Yamashita, R Ishiguro, J Kanzaki, K Kameyama, Y Otani.   

Abstract

Matrix metalloproteinase-2 (MMP-2) and membrane type 1-MMP (MT1-MMP) play an important role in the invasion and metastasis of head and neck squamous cell carcinoma (HNSCC), but the mechanism of their regulation is not clearly understood. Recently, granulocyte-macrophage colony-stimulating factor (GM-CSF) has been shown to be associated with cancer invasion and metastasis. We hypothesized that GM-CSF may upregulate MMP-2 and/or MT1-MMP expression in HNSCC cells, and may thereby influence their ability to invade and metastasize. We studied the effects of GM-CSF on the production of MMP-2 and MT1-MMP in HNSCC cell lines SAS and HSC-2. Gelatin zymography of conditioned media derived from HNSCC cells revealed a major band of 68 kDa, which was characterized as proMMP-2. GM-CSF stimulated the production of proMMP-2 in both cell lines in a dose-dependent manner. Treatment with 50 ng/ml GM-CSF for 24 h increased the proMMP-2 activity 3.4-fold in SAS cells and 2.3-fold in HSC-2 cells compared with untreated controls. Northern blot analyses demonstrated that GM-CSF led to elevated mRNA levels of MMP-2 and MT1-MMP in both cell lines. The results identify GM-CSF as a regulator of MMP-2 and MT1-MMP expression in certain types of HNSCC, and suggest that GM-CSF may contribute to the invasiveness of HNSCC through the regulation of MMP-2 and MT1-MMP expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10840163     DOI: 10.1016/s0304-3835(00)00446-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

Review 1.  Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

2.  Aberrant DNA methylation of matrix remodeling and cell adhesion related genes in pterygium.

Authors:  Andri K Riau; Tina T Wong; Wanwen Lan; Sharon N Finger; Shyam S Chaurasia; Ai Hua Hou; Silin Chen; Shang Juan Yu; Louis Tong
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

3.  Fibroblasts regulate monocyte response to ECM-derived matrix: the effects on monocyte adhesion and the production of inflammatory, matrix remodeling, and growth factor proteins.

Authors:  Amy S Chung; Weiyuan John Kao
Journal:  J Biomed Mater Res A       Date:  2009-06-15       Impact factor: 4.396

4.  Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas.

Authors:  Marcin Nowak; Janusz A Madej; Bartosz Pula; Piotr Dziegiel; Rafal Ciaputa
Journal:  Ir Vet J       Date:  2016-08-02       Impact factor: 2.146

5.  Molecular Changes on Maternal-Fetal Interface in Placental Abruption-A Systematic Review.

Authors:  Monika Bączkowska; Magdalena Zgliczyńska; Jan Faryna; Ewa Przytuła; Błażej Nowakowski; Michał Ciebiera
Journal:  Int J Mol Sci       Date:  2021-06-21       Impact factor: 5.923

6.  GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression.

Authors:  Claudia M Gutschalk; Archana K Yanamandra; Nina Linde; Alice Meides; Sofia Depner; Margareta M Mueller
Journal:  Cancer Med       Date:  2012-11-26       Impact factor: 4.452

Review 7.  Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types.

Authors:  In-Sun Hong
Journal:  Exp Mol Med       Date:  2016-07-01       Impact factor: 8.718

Review 8.  Membrane-type I matrix metalloproteinase (MT1-MMP), lipid metabolism, and therapeutic implications.

Authors:  Xiao-Dan Xia; Adekunle Alabi; Maggie Wang; Hong-Mei Gu; Rui Zhe Yang; Gui-Qing Wang; Da-Wei Zhang
Journal:  J Mol Cell Biol       Date:  2021-10-21       Impact factor: 6.216

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.